These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6667281)

  • 21. [Lipid fractions in low density lipoproteins].
    Ilinov P; Popnikolov S
    Vutr Boles; 1973; 12(6):80-7. PubMed ID: 4783965
    [No Abstract]   [Full Text] [Related]  

  • 22. [Alpha-cholesterol (HDL-cholesterol) and other serum lipid fractions in subjects of low socioeconomic level with healed myocardial infarct].
    Giannini SD; Forti N; Di Rienzo F; Netto MP; Adler R; Almeida A
    Arq Bras Cardiol; 1983 Jun; 40(6):371-5. PubMed ID: 6667146
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of heparin and clofibrate on blood-serum lipid levels in patients with ischaemic heart disease.
    Haviar V; Riecanský L; Kusá O; Luknárová O
    Cor Vasa; 1972; 14(3):188-96. PubMed ID: 4344417
    [No Abstract]   [Full Text] [Related]  

  • 24. Fatty acid composition of platelets and of plasma lipid esters in relation to platelet function in patients with ischaemic heart disease.
    Boberg M; Vessby B; Croon LB
    Atherosclerosis; 1985 Dec; 58(1-3):49-63. PubMed ID: 2936356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HDL-cholesterol concentration and severity of coronary atherosclerosis determined by cine-angiography.
    Naito HK; Greenstreet RL; David JA; Sheldon WL; Shirey EK; Lewis RC; Proudfit WL; Gerrity RG
    Artery; 1980; 8(2):101-12. PubMed ID: 7458675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum lipoproteins in patients with myocardial infarction.
    Kauppinen-Mäkelin R; Nikkilä EA
    Atherosclerosis; 1988 Nov; 74(1-2):65-74. PubMed ID: 3214482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in the share of phosphatidylcholine in total phospholipid concentration in patients with ischaemic heart disease and after myocardial infarction (author's transl)].
    Votruba M; Schmidtová H; Rouchal J; Vacková V
    Cas Lek Cesk; 1981 Jul; 120(27):823-5. PubMed ID: 7261003
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum lipids and lipoprotein concentrations during the acute phase of myocardial infarction.
    Heldenberg D; Rubinstein A; Levtov O; Berns L; Werbin B; Tamir I
    Atherosclerosis; 1980 Apr; 35(4):433-7. PubMed ID: 7378123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma lipids and lipoproteins in Japanese male patients with coronary artery disease and in their relatives.
    Kukita H; Imamura Y; Hamada M; Joh T; Kokubu T
    Atherosclerosis; 1982 Mar; 42(1):21-9. PubMed ID: 7082416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipoprotein spectrum and makeup of the individual classes in coronary arteriosclerosis with a varying lipid level in the blood plasma].
    Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaia TI; Gadzhalova SI
    Kardiologiia; 1980 May; 20(5):42-6. PubMed ID: 7392382
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of lipids (cholesterol, triglycerides and phospholipids), plasma lipoproteins (HDL-cholesterol) and apoproteins (apo A and apo B in patients with acute myocardial infarction].
    Paniagua J; Martínez Muñoz A; Tuset N; Gras J
    Med Clin (Barc); 1989 Jun; 93(4):134-8. PubMed ID: 2796436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Phospholipid content of subfractions of high density lipoproteins in women with angiographically documented coronary arteriosclerosis].
    Maĭ FT; Liakishev AA; Polesskiĭ VA; Sidorenko BA; Gerasimova EN
    Kardiologiia; 1983 Mar; 23(3):33-7. PubMed ID: 6855058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Behavior of blood lipids and lipoproteins in myocardial infarct].
    Del Regno F; Bucciero G; Cardone G; Ascione A; Varano R
    Minerva Med; 1977 Mar; 68(13):847-52. PubMed ID: 191770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDL2 and HDL3 lipid levels in coronary artery disease.
    Wallentin L; Sundin B
    Atherosclerosis; 1986 Feb; 59(2):131-6. PubMed ID: 3964340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
    Bukowska H
    Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggregation of plasma lipids and lipoproteins in families with and without coronary heart disease.
    Friedlander Y; Kark JD; Fainaru M; Gotsman M; Stein Y
    Atherosclerosis; 1985 Nov; 57(2-3):235-47. PubMed ID: 4084357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma HDL-cholesterol has an effect on nitric oxide production and arachidonic acid metabolism in the platelet membranes of coronary heart disease patients without LDL-hypercholesterolemia.
    Tretjakovs P; Kalnins U; Dabina I; Dinne I; Erglis A; Kumsars I; Jurka A
    Med Sci Monit; 2000; 6(3):507-11. PubMed ID: 11208362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Does HDL-cholesterol determination facilitate the assessment of risk in coronary patients?].
    Schmid B; Hartmann G
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1923-5. PubMed ID: 6665537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelets, coagulation and fibrinolysis in diabetic and non-diabetic patients with quiescent coronary heart disease.
    Badawi H; el-Sawy M; Mikhail M; Nomeir AM; Tewfik S
    Angiology; 1970 Sep; 21(8):511-9. PubMed ID: 5507352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.